Answer
Mar 27, 2025 - 03:45 PM
Asenapine carries a black box warning regarding an increased risk of death in elderly patients with dementia-related psychosis. This risk is common to antipsychotic medications and is not approved for the treatment of dementia-related psychosis. It is important for healthcare providers to weigh the benefits and risks when considering asenapine for other approved indications.
